Elisabeth Flo-Groeneboom

Position

Professor

Affiliation

Research groups

Research

Elisabeth Flo-Groeneboom is a psychologist and professor at the Department of Clinical Psychology, Faculty of Psychology, University of Bergen (UiB), and leader of the Human Light Lab and the Bergen Research group for Innovation, Growth, Health and Technology (BRIGHT).

Following a PhD in sleep medicine, Elisabeth worked at the Center for Geriatric and Nursing Home Medicine at the Faculty of Medicine, UiB.

Today, her research and teaching at MScs and PhD level courses focus on non-pharmacological interventions, sleep and circadian rhythms, mental health challenges over the lifespan, and functioning in older adults and people with dementia.

Current research is of a translational nature with a clinical applied focus, from experiments in the light lab to implementing multicomponent interventions in large-scale Randomized Controlled Trials (RCT).

Publications
Programme management
Lecture
Interview
Poster
Article in business/trade/industry journal
Interview Journal
Popular scientific article
Academic lecture
Popular scientific lecture
Academic article
Programme participation
Academic literature review
Abstract
Non-fiction book
Doctoral dissertation
Errata
Feature article

See a complete overview of publications in Cristin.

Projects

ENLIGHT Optimal light conditions for improved memory and mood

The ENLIGHT project investigates whether light therapy represents an effective way to improve the lives of people with dementia. The lack of studies on light as a non-pharmacological therapy including people with dementia makes this important for further theoretical and methodological development.

COSMOS

COSMOS (COmmunication, Systematic pain assessment and treatment, Medication review, Organization of activities, and Safety) is a practical intervention aimed to improve the quality of life in nursing home patients. The intervention combines the most effective research results to improve staff competence, and patients’ mental health, safety, quality of life and to reduce psychotropic drug use and costs. A total of 545 patients from 67 nursing home units from the eastern and western part of Norway were included.